ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly strattera (atomoxetine) — Worldwide revenue ($M) [legacy separate disclosure] ($M)
Form 10-Q / 10-K Note 2 & MD&A (legacy separate product disclosure prior to FY2025 reorganization)
Latest, Q4 2019
250
Period ended Dec 31, 2019
Change on a year earlier
-9.0%
275 in Q4 2018
History
12 quarters
Since Q1 2017
Sources
9
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Strattera (atomoxetine) — Worldwide revenue ($M) [legacy separate disclosure] ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | 250 | -9.0% | Form 10-K FY2019 (filed 2020-02-19) ↗ |
| Q3 2019 | Sep 30, 2019 | 52.1 | -47.2% | Form 10-Q (filed 2019-10-25) ↗ |
| Q2 2019 | Jun 30, 2019 | 82.6 | -27.7% | Form 10-Q (filed 2019-08-02) ↗ |
| Q1 2019 | Mar 31, 2019 | 66.2 | -49.3% | Form 10-Q (filed 2019-05-02) ↗ |
| Q4 2018 | Dec 31, 2018 | 275 | +179.5% | Form 10-K FY2018 (filed 2019-02-19) ↗ |
| Q3 2018 | Sep 30, 2018 | 98.7 | -28.0% | Form 10-Q (filed 2019-10-25) ↗ |
| Q2 2018 | Jun 30, 2018 | 114 | -38.8% | Form 10-Q (filed 2019-08-02) ↗ |
| Q1 2018 | Mar 31, 2018 | 131 | -33.4% | Form 10-Q (filed 2019-05-02) ↗ |
| Q4 2017 | Dec 31, 2017 | 98.3 | – | Form 10-K (filed 2018-02-20) ↗ |
| Q3 2017 | Sep 30, 2017 | 137 | – | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2017 | Jun 30, 2017 | 187 | – | Form 10-Q (filed 2018-07-25) ↗ |
| Q1 2017 | Mar 31, 2017 | 196 | – | Form 10-Q (filed 2018-04-27) ↗ |
Breakdown
What makes up strattera (atomoxetine) — worldwide revenue ($m) [legacy separate disclosure]
Cite this data
StockData. (2026). Eli Lilly Strattera (atomoxetine) — Worldwide revenue ($M) [legacy separate disclosure] ($M), quarterly Q1 2017–Q4 2019 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med_strattera_ww
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.